Robert Lupinacci

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein et al. · New England Journal of Medicine · 2002 · 1.4K citations · Full text

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 917 citations · Full text

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

Álvaro Villanueva, Eduardo Gotuzzo, Eduardo Arathoon et al. · The American Journal of Medicine · 2002 · 291 citations

Antifungal Agent, Antifungal Agents, Clinical Mycology +4

Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis

Arnaldo Lopes Colombo, John R. Perfect, Mark J. DiNubile et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2003 · 127 citations

Antifungal Agent, Health Sciences, Fungal Pathogen +9

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · European Journal of Cancer · 2019 · 80 citations

Surgical Oncology, Medicine, Melanoma +10